The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | V | Various | |
| 2 | V08 | Contrast media | |
| 3 | V08C | Magnetic resonance imaging contrast media | |
| 4 | V08CA | Paramagnetic contrast media | |
| 5 | V08CA10 | Gadoxetic acid |
| Active Ingredient | Description | |
|---|---|---|
| Gadoxetic acid |
Gadoxetic acid is a paramagnetic contrast agent for magnetic resonance imaging. The contrast-enhancing effect is mediated by gadoxetate (Gd EOB DTPA), an ionic complex consisting of gadolinium (III) and the ligand ethoxybenzyl-diethylenetriamine-pentaacetic acid (EOB-DTPA). |
| Title | Information Source | Document Type | |
|---|---|---|---|
| PRIMOVIST Solution for injection | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
